A detailed history of Caxton Associates LP transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 29,150 shares of AMRX stock, worth $227,078. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,150
Holding current value
$227,078
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.42 - $8.83 $187,143 - $257,394
29,150 New
29,150 $242,000
Q1 2024

May 15, 2024

BUY
$5.24 - $6.34 $42,381 - $51,277
8,088 Added 9.7%
91,481 $554,000
Q4 2023

Feb 14, 2024

SELL
$3.36 - $6.21 $123,940 - $229,068
-36,887 Reduced 30.67%
83,393 $506,000
Q3 2023

Nov 14, 2023

BUY
$2.76 - $4.59 $331,972 - $552,085
120,280 New
120,280 $507,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.18B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.